Hematological profile of hospitalized children in post-COVID-19 infection state
1 Pediatrician, General Pediatric Ward, “Mother Teresa”, Tirana, Albania.
2 Professor Chef of Pediatric Infectious Disease Ward, University Hospital Center, “Mother Teresa”, Tirana, Albania.
3 Psychologist at General Pediatric Ward, University Hospital Center “Mother Teresa”, Tirana, Albania.
4 Radiologist American Hospital Center, Pristina, Kosovo.
Research Article
World Journal of Advanced Research and Reviews, 2024, 23(02), 1712–1718
Publication history:
Received on 12 July 2024; revised on 19 August 2024; accepted on 21 August 2024
Abstract:
Coronavirus Disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the first global pandemic of the 21-th century. Even though the COVID-19 public health emergency ended, COVID-19 continues to be a health risk. COVID-19 in children appeared early in the pandemic. Children were less affected or suffered from milder disease than adults, however soon after multisystem inflammatory syndrome emerged. This study aims to explore hematological findings in hospitalized children presented in post SARS CoV-2 infection state. Of the 87 children included in the study 55% had leukocytosis, 58% had thrombocytosis, 66% had elevated CRP, 62% had elevated Fibrinogen, 37% had elevated Ferritin, and 32% had elevated D-dimer. The hemostatic system is mostly affected by the Multisystem Inflammatory Syndrome in children that follows SARS CoV-2 infection, leukocytosis, elevated CRP, Fibrinogen, Ferritin, and D-dimer are the most common findings. A careful monitoring of hematological and inflammatory parameters is recommended while evaluating children with MIS-C.
Keywords:
COVID-19; MIS-C; Hematological; Inflammatory; Marker.
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0